Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Single Centre, open label assignment phase II clinical study.
To evaluate the effect of oral 200mg Methylene Blue tablets (administered 8x25mg) prior to
endoscopy on double stranded DNA breaks in colonic biopsy samples assessed by histone gamma
H2AX analysis, compared to control biopsies.